Top Markets
Coin of the day
Biostage, Inc. Biostage, Inc.

Biostage, Inc.

BSTG
Rang in Aktien #24995
Biostage, Inc. is a biotechnology enterprise dedicated to developing medical... Biostage, Inc. is a biotechnology enterprise dedicated to developing medical products aimed at curing patients suffering from cancers, injuries, and congenital defects within the gastrointestinal system and respiratory pathways. A primary focus for the company is the advancement of its Biostage Esophageal Implant, specifically designed to address esophageal cancer. Founded in 2009, the organization was formerly known as Harvard Apparatus Regenerative Technology, Inc. before rebranding as Biostage, Inc. in March 2016. Its corporate headquarters are located in Holliston, Massachusetts.
Aktienkurs
$3.95
Zuletzt synchronisiert: 2023-08-15
Marktkapitalisierung
$54.45M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Biostage, Inc. (BSTG)

Kategorie

Dividendenrendite-Verlauf für Biostage, Inc. (BSTG)
Dividendenrendite (TTM) von Biostage, Inc. (Aktienkürzel: BSTG) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Biostage, Inc. (BSTG) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.00%
US